Includes reviews of Mercedes-Benz of Walnut Creek from DealerRater. Want to share your experience with this dealership? I had an amazing experience with Uri and Thomas. They was very patient and ...

Shares in financial firm Stifel (SF) dropped 3% today after it was told to cough up $132.5 million in damages to a U.S. family who suffered from poor advice. Staggering Losses for Family Stifel ...

(Reuters) - Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million for misrepresenting the risk of complex structured notes ...

A Finra arbitration panel has ordered Stifel Financial Corp. to pay about $132 million in damages for allegedly misleading investors by pitching a product as less risky than it actually was ...

Stifel has been hit with a large penalty in an arbitration case stemming from a broker’s structured-notes strategy that has resulted in more than a dozen investor complaints.

David Jannetti and family members in 2023 sued Stifel Nicolaus & Co., the broker-dealer subsidiary of Stifel Financial, claiming at least $5 million in damages related to investments in structured ...

Finra panel says Stifel was 'required to have heightened supervision' of a broker A Finra arbitration panel has ordered Stifel Financial Corp. to pay about $132 million in damages for allegedly ...

(Reuters) - Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million for misrepresenting the risk of complex structured notes, causing ...

Contineum Therapeutics (Nasdaq: CTNM) is a clinical-stage biopharmaceutical company pioneering novel, oral small molecule therapies for NI&I indications with significant unmet need. Contineum is ...

Stifel Nicolaus analyst Shlomo Rosenbaum maintained a Buy rating on Clarivate (CLVT – Research Report) today and set a price target of $8.00. The company’s shares closed yesterday at $4.07 ...

On Friday, Stifel analysts highlighted a selection of Med-Tech stocks that present favorable risk/reward opportunities, despite the industry’s current challenges with back-end weighted guidance ...